---
title: "SL Science slips 10% in after-hours trading amid 5-day 21% rally"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291585236.md"
description: "SLBT tumbles 10% after-hours to $5.40 despite 21% five-day gain; fiscal 2025 loss widens to $3.82M."
datetime: "2026-07-02T20:21:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291585236.md)
  - [en](https://longbridge.com/en/news/291585236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291585236.md)
---

# SL Science slips 10% in after-hours trading amid 5-day 21% rally

SL Science(SLBT.US) 盘后下跌**9.85%**，现报**5.40**美元。

近期消息面显示，该股 5 个交易日内累计涨幅超过**21%**，资金活跃但缺乏正面消息支撑。此前公司披露 2025 财年业绩，净亏损扩大至**382**万美元，营收同比下降**35%**至**220**万美元，主要受台湾地区外泌体业务从零售转向批发模式影响。公司于 6 月中旬完成 SPAC 合并并在纳斯达克上市，同期完成**780**万美元 PIPE 融资。

### Related Stocks

- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)

## Related News & Research

- [SL Science Seeks FDA Orphan Drug Status for Gamma Delta T Cell Therapy in Glioblastoma](https://longbridge.com/en/news/292326758.md)
- [SL Science Holding files Form 3 as CEO Ching-Dong Wang reports 333,832,129 shares beneficially owned](https://longbridge.com/en/news/290244372.md)
- [Ching-Dong Wang Discloses Investment at SL Science Holding Ltd with 59.53% Stake](https://longbridge.com/en/news/290245423.md)
- [SL Science FY25 net loss widens to USD 3.82 million; revenue falls 35% to USD 2.2 million](https://longbridge.com/en/news/290247592.md)
- [SL Science Holding Limited Reports Full Year 2025 Financial Results | SLBT Stock News](https://longbridge.com/en/news/290247925.md)